T0	Outcomes 1350 1370	Treatment reduced BP
T1	Outcomes 1376 1390	similar extent
T2	Outcomes 1407 1443	Valsartan significantly reduced LVMI
T3	Outcomes 1483 1494	less effect
T4	Outcomes 1529 1558	Formation of ROS by monocytes
T5	Outcomes 1563 1590	reduced to a greater extent
T6	Outcomes 1688 1707	reduced CRP levels.
T7	Outcomes 1710 1733	significant correlation
T8	Outcomes 1742 1812	changes in ROS formation by monocytes and LVMI or between CRP and LVMI